UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Preexisting Autoimmune Disease: Implications for Immune Checkpoint Inhibitor Therapy in Solid Tumors

Journal of the National Comprehensive Cancer Network, 2019-06, Vol.17 (6), p.750-757

2019

Volltextzugriff (PDF)

A New Era for Cancer Treatment: Gold-Nanoparticle-Mediated Thermal Therapies

Small (Weinheim an der Bergstrasse, Germany), 2011-01, Vol.7 (2), p.169-183

2011

Volltextzugriff (PDF)

Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transfer

PloS one, 2013-07, Vol.8 (7), p.e69073

2013

Volltextzugriff (PDF)

Associations of Multiparametric Breast MRI Features, Tumor-Infiltrating Lymphocytes, and Immune Gene Signature Scores Following a Single Dose of Trastuzumab in HER2-Positive Early-Stage Breast Cancer

Cancers, 2023-08, Vol.15 (17), p.4337

2023

Volltextzugriff (PDF)

Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues

Clinical chemistry (Baltimore, Md.), 2021-07, Vol.67 (7), p.1008-1018

2021

Volltextzugriff (PDF)

“Those Conversations in My Experience Don’t Go Well”: A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications

Pain medicine (Malden, Mass.), 2018-11, Vol.19 (11), p.2201-2211

2018

Volltextzugriff (PDF)

Associations of Immune Checkpoint Predictive Biomarkers (MHC-I and MHC-II) with Clinical and Molecular Features in a Diverse Breast Cancer Cohort

Clinical cancer research, 2024-09, Vol.30 (18), p.4077-4081

2024

Volltextzugriff (PDF)

New targets in endocrine-resistant hormone receptor-positive breast cancer

Clinical advances in hematology & oncology, 2021-08, Vol.19 (8), p.511-521

2021

Volltextzugriff (PDF)

Immunotherapy-Related Colitis: An Emerging Challenge and a Quest for Prospective Data

JCO oncology practice, 2020-08, Vol.16 (8), p.464-465

2020

Volltextzugriff (PDF)

Dasatinib in breast cancer: Src-ing for response in all the wrong kinases

Annals of translational medicine, 2018-11, Vol.6 (Suppl 1), p.S60-S60

2018

Volltextzugriff (PDF)

T cells enhance gold nanoparticle delivery to tumors in vivo

Nanoscale research letters, 2011-04, Vol.6 (1), p.283-283, Article 283

2011

Volltextzugriff (PDF)

Liquid Biopsy Assessment of Circulating Tumor Cell PD-L1 and IRF-1 Expression in Patients with Advanced Solid Tumors Receiving Immune Checkpoint Inhibitor

Targeted oncology, 2022-05, Vol.17 (3), p.329-341

2022

Volltextzugriff (PDF)

Untangling the Multidisciplinary Care Web: Streamlining Care Through an Immune-Related Adverse Events (IRAE) Tumor Board

Targeted oncology, 2020-08, Vol.15 (4), p.541-548

2020

Volltextzugriff (PDF)

Rapid Stereomicroscopic Imaging of HER2 Overexpression in Ex Vivo Breast Tissue Using Topically Applied Silica-Based Gold Nanoshells

Journal of Oncology, 2012-01, Vol.2012 (2012), p.177-186-020

2012

Volltextzugriff (PDF)

Size-controlled synthesis of monodispersed gold nanoparticles via carbon monoxide gas reduction

Nanoscale research letters, 2011-06, Vol.6 (1), p.428-428, Article 428

2011

Volltextzugriff (PDF)

Abstract PD11-08: Associations of baseline breast MRI metrics and immune infiltration with chemotherapy response in triple negative breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD11-08-PD11-08

2022

Volltextzugriff (PDF)

Abstract P2-23-05: Trastuzumab-Induced Tumor Microenvironment Changes in Early HER2+ Breast Cancer

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P2-P2-23-05

2023

Volltextzugriff (PDF)

Abstract CT271: Neoadjuvant targeted therapy in stage I-III HER2-mutant lobular breast cancer

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.CT271-CT271

2024

Volltextzugriff (PDF)

Abstract 5980: Identification of pre-treatment tumor habitats for the prediction of neoadjuvant therapy response in triple negative breast cancer

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.5980-5980

2022

Volltextzugriff (PDF)

Abstract 1981: Immune related liver toxicity and potential risk factors: A case-control study

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.1981-1981

2022

Volltextzugriff (PDF)

Abstract 2719: Tumor-associated macrophage reprogramming by novel nano-in-cryogel biomaterials for breast cancer immunotherapy

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2719-2719

2023

Volltextzugriff (PDF)

Abstract GS5-03: Evaluation of anti-PD-1 Cemiplimab plus anti-LAG-3 REGN3767 in early-stage, high-risk HER2-negative breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.GS5-03-GS5-03

2023

Volltextzugriff (PDF)

Childhood Precursors of Adult Trait Incompleteness

Kennedy, Laura C

2016

Volltextzugriff (PDF)

Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics

Cell, 2017-11, Vol.171 (5), p.1165-1175.e13

2017

Volltextzugriff (PDF)

Mapping anorexia nervosa genes to clinical phenotypes

Psychological medicine, 2023-04, Vol.53 (6), p.2619-2633

2023

Volltextzugriff (PDF)

1 – 25 von 445

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(413)
Mit Volltextzugriff
(374)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(443)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Preexisting Autoimmune Disease: Implications for Immune Checkpoint Inhibitor Therapy in Solid Tumors

A New Era for Cancer Treatment: Gold-Nanoparticle-Mediated Thermal Therapies

Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transfer

Associations of Multiparametric Breast MRI Features, Tumor-Infiltrating Lymphocytes, and Immune Gene Signature Scores Following a Single Dose of Trastuzumab in HER2-Positive Early-Stage Breast Cancer

Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues

“Those Conversations in My Experience Don’t Go Well”: A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications

Associations of Immune Checkpoint Predictive Biomarkers (MHC-I and MHC-II) with Clinical and Molecular Features in a Diverse Breast Cancer Cohort

New targets in endocrine-resistant hormone receptor-positive breast cancer

Immunotherapy-Related Colitis: An Emerging Challenge and a Quest for Prospective Data

Dasatinib in breast cancer: Src-ing for response in all the wrong kinases

T cells enhance gold nanoparticle delivery to tumors in vivo

Liquid Biopsy Assessment of Circulating Tumor Cell PD-L1 and IRF-1 Expression in Patients with Advanced Solid Tumors Receiving Immune Checkpoint Inhibitor

Untangling the Multidisciplinary Care Web: Streamlining Care Through an Immune-Related Adverse Events (IRAE) Tumor Board

Rapid Stereomicroscopic Imaging of HER2 Overexpression in Ex Vivo Breast Tissue Using Topically Applied Silica-Based Gold Nanoshells

Size-controlled synthesis of monodispersed gold nanoparticles via carbon monoxide gas reduction

Abstract PD11-08: Associations of baseline breast MRI metrics and immune infiltration with chemotherapy response in triple negative breast cancer

Abstract P2-23-05: Trastuzumab-Induced Tumor Microenvironment Changes in Early HER2+ Breast Cancer

Abstract CT271: Neoadjuvant targeted therapy in stage I-III HER2-mutant lobular breast cancer

Abstract 5980: Identification of pre-treatment tumor habitats for the prediction of neoadjuvant therapy response in triple negative breast cancer

Abstract 1981: Immune related liver toxicity and potential risk factors: A case-control study

Abstract 2719: Tumor-associated macrophage reprogramming by novel nano-in-cryogel biomaterials for breast cancer immunotherapy

Abstract GS5-03: Evaluation of anti-PD-1 Cemiplimab plus anti-LAG-3 REGN3767 in early-stage, high-risk HER2-negative breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL

Childhood Precursors of Adult Trait Incompleteness

Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics

Mapping anorexia nervosa genes to clinical phenotypes

Suchergebnisse filtern